Related Experiment Video

Updated: May 25, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Downregulation of insulin-like growth factor-binding protein 7 in cisplatin-resistant non-small cell lung cancer

Jun Okamura1, Yiping Huang, David Moon

  • 1Department of Otolaryngology, Head and Neck Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Cancer Biology & Therapy
|January 27, 2012
PubMed

Insights

Loss of Insulin-like growth factor-binding protein 7 (IGFBP7) contributes to cisplatin resistance in non-small cell lung cancer. Restoring IGFBP7 may resensitize tumors to this chemotherapy, offering new treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Cisplatin is a key chemotherapy for non-small cell lung cancer (NSCLC).
  • Drug resistance limits cisplatin's efficacy.
  • Insulin-like growth factor-binding protein 7 (IGFBP7) is a tumor suppressor often inactivated in lung cancer.

Purpose of the Study:

  • To investigate the role of IGFBP7 loss in cisplatin chemo-resistance.
  • To explore the molecular mechanisms linking IGFBP7 and cisplatin resistance.

Main Methods:

  • Analysis of IGFBP7 transcriptional levels in cisplatin-resistant cell lines and xenografts.
  • Experimental manipulation of IGFBP7 and mitogen-activated protein kinase phosphatase 3 (MKP3) expression via knockdown.
  • Assessment of cellular resistance to cisplatin.

Main Results:

  • IGFBP7 levels were decreased in cisplatin-resistant NSCLC models.
  • IGFBP7 knockdown enhanced cisplatin resistance and increased MKP3 levels.
  • MKP3 knockdown increased IGFBP7 levels, indicating MKP3 regulates IGFBP7.

Conclusions:

  • Loss of IGFBP7 is a mechanism contributing to cisplatin resistance in NSCLC.
  • A novel molecular pathway involving IGFBP7 and MKP3 in chemo-resistance was identified.
  • IGFBP7 holds potential as a therapeutic agent to overcome cisplatin resistance.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...